AI English summary of an SEC filing — figures as filed
For Q4 2025, the company reported net earnings of $456 million, diluted EPS of $0.94 and adjusted EPS of $0.87. Adjusted EPS was 24% lower than $1.14 in the prior year quarter.
Key points
AI summaryFor Q4 2025, the company reported net earnings of $456 million, diluted EPS of $0.94 and adjusted EPS of $0.87. Adjusted EPS was 24% lower than $1.14 in the prior year quarter.
For 2025, the company reported net earnings of $1.1 billion, diluted EPS of $2.23 and adjusted EPS of $3.43. Adjusted EPS declined 28% versus the prior year. Total segment operating profit was $3.2 billion, down 23%.
For Q4 2025, the company reported Ag Services & Oilseeds segment operating profit of $444 million, down 31% compared to the prior year quarter, Carbohydrate Solutions of $299 million, down 6%, and Nutrition of $78 million, down 11%.
The company expects 2026 adjusted EPS of approximately $3.60 to $4.25, with capital expenditures projected to be in the range of $1.3 to $1.5 billion. The company said the lower end of the range reflects continued U.S. biofuel policy deferral and flat crush margins.
Summary
AI-writtenAnalysis scope · Filing body and confirmed press-release exhibitWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.
Q4 Net Earnings $456 million, Adjusted EPS $0.87
For Q4 2025, the company reported net earnings of $456 million, diluted EPS of $0.94 and adjusted EPS of $0.87. Adjusted EPS was 24% lower than $1.14 in the prior year quarter.
Source · Based on the filing body and exhibits
2025 Net Earnings $1.1 billion, Adjusted EPS $3.43
For 2025, the company reported net earnings of $1.1 billion, diluted EPS of $2.23 and adjusted EPS of $3.43. Adjusted EPS declined 28% versus the prior year. Total segment operating profit was $3.2 billion, down 23%.
Source · Based on the filing body and exhibits
Q4 Segment Operating Profit Changes
For Q4 2025, the company reported Ag Services & Oilseeds segment operating profit of $444 million, down 31% compared to the prior year quarter, Carbohydrate Solutions of $299 million, down 6%, and Nutrition of $78 million, down 11%.
Source · Based on the filing body and exhibits
2026 Adjusted EPS Outlook and Capital Expenditure Plan
The company expects 2026 adjusted EPS of approximately $3.60 to $4.25, with capital expenditures projected to be in the range of $1.3 to $1.5 billion. The company said the lower end of the range reflects continued U.S. biofuel policy deferral and flat crush margins.
Source · Based on the filing body and exhibits
AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.
Original filing
The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.
Loading the filing text…